Lucira Health (LHDXQ) and Its Peers Critical Review
Lucira Health (LHDXQ) and Its Peers Critical Review
Lucira Health (NASDAQ:LHDXQ – Get Rating) is one of 41 public companies in the "Diagnostic substances" industry, but how does it contrast to its rivals? We will compare Lucira Health to related businesses based on the strength of its valuation, risk, analyst recommendations, profitability, dividends, earnings and institutional ownership.
Lucira Health（纳斯达克股票代码：LHDXQ — 获取评级）是 “诊断物质” 行业的41家上市公司之一，但它与竞争对手相比有何不同？我们将根据Lucira Health的估值、风险、分析师建议、盈利能力、股息、收益和机构所有权的实力，将Lucira Health与相关业务进行比较。
Analyst Ratings
分析师评级
This is a breakdown of current ratings and price targets for Lucira Health and its rivals, as provided by MarketBeat.
这是MarketBeat提供的Lucira Health及其竞争对手目前的评级和目标价格的明细。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Lucira Health | 0 | 0 | 0 | 0 | N/A |
| Lucira Health Competitors | 373 | 632 | 1237 | 19 | 2.40 |
| 卖出评级 | 保持收视率 | 买入评级 | 强劲的买入评级 | 评分分数 | |
| 露西拉健康 | 0 | 0 | 0 | 0 | 不适用 |
| 露西拉健康竞争对手 | 373 | 632 | 1237 | 19 | 2.40 |
As a group, "Diagnostic substances" companies have a potential upside of 38.58%. Given Lucira Health's rivals higher probable upside, analysts plainly believe Lucira Health has less favorable growth aspects than its rivals.
作为一个整体，“诊断物质” 公司的潜在上涨空间为38.58％。鉴于Lucira Health的竞争对手可能有更高的上行空间，分析师显然认为Lucira Health的增长方面不如竞争对手那么有利。
Institutional & Insider Ownership
机构所有权和内部所有权
57.0% of Lucira Health shares are held by institutional investors. Comparatively, 46.6% of shares of all "Diagnostic substances" companies are held by institutional investors. 30.4% of Lucira Health shares are held by insiders. Comparatively, 14.1% of shares of all "Diagnostic substances" companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Lucira Health的57.0％股票由机构投资者持有。相比之下，所有 “诊断物质” 公司的46.6％的股份由机构投资者持有。Lucira Health的股份中有30.4％由内部人士持有。相比之下，所有 “诊断物质” 公司的14.1％的股份由内部人士持有。强大的机构所有权表明大型基金经理、对冲基金和捐赠机构认为，从长远来看，一家公司的表现将优于市场。
Earnings & Valuation
收益与估值
This table compares Lucira Health and its rivals gross revenue, earnings per share and valuation.
该表比较了Lucira Health及其竞争对手的总收入、每股收益和估值。
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Lucira Health | $93.06 million | -$64.83 million | -0.01 |
| Lucira Health Competitors | $472.03 million | $10.25 million | -53.53 |
| 总收入 | 净收入 | 市盈率 | |
| 露西拉健康 | 9306 万美元 | -6,483 万美元 | -0.01 |
| 露西拉健康竞争对手 | 4.7203 亿美元 | 1,025 万美元 | -53.53 |
Lucira Health's rivals have higher revenue and earnings than Lucira Health. Lucira Health is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Lucira Health的竞争对手的收入和收益高于Lucira Health。Lucira Health的市盈率高于竞争对手，这表明它目前比该行业的其他公司更昂贵。
Risk and Volatility
风险和波动性
Lucira Health has a beta of 3.36, suggesting that its stock price is 236% more volatile than the S&P 500. Comparatively, Lucira Health's rivals have a beta of 1.36, suggesting that their average stock price is 36% more volatile than the S&P 500.
Lucira Health的beta值为3.36，这表明其股价的波动性比标准普尔500指数高236％。相比之下，Lucira Health的竞争对手的beta值为1.36，这表明他们的平均股价的波动性比标准普尔500指数高36％。
Profitability
盈利能力
This table compares Lucira Health and its rivals' net margins, return on equity and return on assets.
该表比较了Lucira Health及其竞争对手的净利润率、股本回报率和资产回报率。
| Net Margins | Return on Equity | Return on Assets | |
| Lucira Health | -67.54% | -13.55% | -8.47% |
| Lucira Health Competitors | -802.63% | -114.55% | -27.76% |
| 净利润 | 股本回报率 | 资产回报率 | |
| 露西拉健康 | -67.54% | -13.55% | -8.47% |
| 露西拉健康竞争对手 | -802.63% | -114.55% | -27.76% |
Summary
摘要
Lucira Health beats its rivals on 7 of the 10 factors compared.
在比较的10个因素中，Lucira Health在7个因素上击败了竞争对手。
About Lucira Health
关于 Lucira Health
(Get Rating)
（获取评分）
Lucira Health Inc. is a medical technology company. It is focused on the development and commercialization of transformative and infectious disease test kits. Lucira Health Inc. is based in Emeryville, California.
Lucira Health Inc. 是一家医疗技术公司。它专注于变革性和传染病检测试剂盒的开发和商业化。Lucira Health Inc. 总部位于加利福尼亚州的埃默里维尔。
Receive News & Ratings for Lucira Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lucira Health and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Lucira Health Daily 的新闻和评级 -在下面输入您的电子邮件地址，即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Lucira Health及相关公司的最新新闻和分析师评级的简明每日摘要。